tiprankstipranks
Advertisement
Advertisement

OPHLF Stock Latest News

ONO-6414: New First-in-Human Ulcerative Colitis Study Puts ONO Pharmaceutical on Investors’ Radar
Company AnnouncementsONO-6414: New First-in-Human Ulcerative Colitis Study Puts ONO Pharmaceutical on Investors’ Radar
10d ago
OPHLF
ONO Pharmaceutical Q1: Record Sales, Margin Strain
PremiumCompany Announcements
ONO Pharmaceutical Q1: Record Sales, Margin Strain
15d ago
Ono Pharmaceutical Lifts Q1 Profits Despite Revenue Decline, Confirms FY2026 Outlook
PremiumCompany Announcements
Ono Pharmaceutical Lifts Q1 Profits Despite Revenue Decline, Confirms FY2026 Outlook
17d ago
Ono Pharma Halts Early Lymphoma Trial, Raising Fresh Questions for Investors
PremiumCompany Announcements
Ono Pharma Halts Early Lymphoma Trial, Raising Fresh Questions for Investors
18d ago
OPHLF
OPHLF Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
OPHLF Upcoming Earnings Report: What to Expect?
19d ago
Ono’s New GIST Study Puts Early‑Stage Oncology Back in Focus for OPHLF Investors
PremiumCompany AnnouncementsOno’s New GIST Study Puts Early‑Stage Oncology Back in Focus for OPHLF Investors
27d ago
OPHLF
Ono Pharma’s ONO-1110 Pain Trial Reaches Completion, Setting Up a Key Readout
Premium
Company Announcements
Ono Pharma’s ONO-1110 Pain Trial Reaches Completion, Setting Up a Key Readout
1M ago
OPHLF
ONO-1110 Depression Trial Completion: What It Means for OPHLF Investors
Premium
Company Announcements
ONO-1110 Depression Trial Completion: What It Means for OPHLF Investors
1M ago
OPHLF
ONO’s ONO‑1110 Trial Completion Puts Social Anxiety Bet in Investor Focus
PremiumCompany Announcements
ONO’s ONO‑1110 Trial Completion Puts Social Anxiety Bet in Investor Focus
1M ago
OPHLF
ONO’s Tirabrutinib Liver Study Completion: What It Means for OPHLF Investors
PremiumCompany Announcements
ONO’s Tirabrutinib Liver Study Completion: What It Means for OPHLF Investors
2M ago
OPHLF
Real-World Data on Nivolumab Plus Chemo in Japanese Gastric Cancer: What Investors Should Watch
PremiumCompany Announcements
Real-World Data on Nivolumab Plus Chemo in Japanese Gastric Cancer: What Investors Should Watch
2M ago
BMY
Ono’s ONO-4578 Breast Cancer Combo Clears Phase I Milestone, Setting Up the Next Investor Catalyst
PremiumCompany Announcements
Ono’s ONO-4578 Breast Cancer Combo Clears Phase I Milestone, Setting Up the Next Investor Catalyst
2M ago
OPHLF
ONO’s ONO-7018 Trial Termination: What It Means for OPHLF Investors
PremiumCompany AnnouncementsONO’s ONO-7018 Trial Termination: What It Means for OPHLF Investors
3M ago
OPHLF
Ono’s Real-World Tirabrutinib Study in Taiwan Reaches Completion, Setting Up a New Catalyst for OPHLF
Premium
Company Announcements
Ono’s Real-World Tirabrutinib Study in Taiwan Reaches Completion, Setting Up a New Catalyst for OPHLF
3M ago
OPHLF
Ono’s Phase 3 Sapablursen Trial Targets Polycythemia Vera Upside for OPHLF Investors
Premium
Company Announcements
Ono’s Phase 3 Sapablursen Trial Targets Polycythemia Vera Upside for OPHLF Investors
3M ago
OPHLF
ONO Pharmaceutical Details FY2025 Results and FY2026 Outlook with Focus on Pipeline and Core Metrics
PremiumCompany Announcements
ONO Pharmaceutical Details FY2025 Results and FY2026 Outlook with Focus on Pipeline and Core Metrics
3M ago
Ono Pharmaceutical Delivers Strong FY 2025 Profits but Guides for Lower Revenue in FY 2026
PremiumCompany Announcements
Ono Pharmaceutical Delivers Strong FY 2025 Profits but Guides for Lower Revenue in FY 2026
3M ago
Is OPHLF a Buy, Before Earnings?
PremiumPre-Earnings
Is OPHLF a Buy, Before Earnings?
3M ago
ONO Pharmaceutical Nears Key Readout in Lung Cancer Combo Trial With Tagrisso
PremiumCompany Announcements
ONO Pharmaceutical Nears Key Readout in Lung Cancer Combo Trial With Tagrisso
5M ago
OPHLF
ONO Pharmaceutical Posts Strong Profit Growth in Q3 FY2025 and Maintains Full-Year Outlook
PremiumCompany AnnouncementsONO Pharmaceutical Posts Strong Profit Growth in Q3 FY2025 and Maintains Full-Year Outlook
7M ago
OPHLF Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
OPHLF Earnings this Week: How Will it Perform?
7M ago
ONO Pharmaceutical Reports Strong Q2 Financial Performance with Revenue Growth
Premium
Company Announcements
ONO Pharmaceutical Reports Strong Q2 Financial Performance with Revenue Growth
10M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >